JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smyth, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smyth, D. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Carbamylation of Amino and Tyrosine Hydroxyl Groups

PREPARATION OF AN INHIBITOR OF OXYTOCIN WITH NO INTRINSIC ACTIVITY ON THE ISOLATED UTERUS

Derek G. Smyth 1

From the 1 From the National Institute for Medical Research, Mill Hill, London, N.W. 7, England

The reactions of cyanate with model compounds containing amino and tyrosine hydroxyl groups have been studied in detail. The reactions involve nucleophilic addition of the amino or phenoxide group to the molecular form of cyanic acid. The proposed mechanism of the reactions has aided in the selection of optimal experimental conditions for the carbamylation of amino and tyrosine hydroxyl groups in proteins and peptides. Carbamylation represents a useful reaction for the reversible blocking of tyrosine hydroxyl groups, the O-carbamyl substituent being readily removed by hydrolysis at neutral and alkaline pH values. By application of the cyanate reaction to oxytocin, two new analogues were obtained, N-carbamyl-O-carbamyloxytocin and N-carbamyloxytocin. The sites of reaction and degree of purity were determined by experiments involving degradation of the molecules and by the use of radioactive labeling. On the isolated uterus, N-carbamyl-O-carbamyloxytocin acts as an inhibitor of oxytocin without itself possessing oxytocic activity; N-carbamyloxytocin is a feebly active analogue with no inhibitory properties. At pH 7.4 and 37°, the inhibitory analogue undergoes slow hydrolysis to yield the weakly active analogue. The very low activity of N-carbamyloxytocin provides an explanation for the inactivation of oxytocin by 8 m urea.

Submitted on March 29, 1966


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1967 by the American Society for Biochemistry and Molecular Biology.